Community oncologists help refer appropriate patients to authorized treatment centers.
Risk for head, neck melanoma higher for male sex, older age, non-Hispanic white ethnicity
Study sought to determine if response to upfront treatment in children and adolescents with Hodgkin lymphoma is influenced by race/ethnicity.
Early discontinuation of rituximab in patients with B-cell non-Hodgkin lymphoma was linked with worse survival.
In this case study, CD19-directed CAR-T therapy was effective in eliminating evidence of both underlying WM as well as transformed high grade B-cell lymphoma.
Researchers conducted a meta-analysis to evaluate possible associations between certain genetic variants and risk for acute lymphoblastic leukemia.
The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures
Screening patients with lung cancer using low-dose computed tomography (LDCT) has been associated with reducing lung cancer mortality as much as 20%, but the technique remains limited.
Occupational exposure account for 30% of all lung cancer diagnosis in the United States.
Next-generation sequencing of circulating tumor DNA (ctDNA) may identify patients who are likely to benefit from targeted therapy for NSCLC.
Researchers found that molecular profiles of patients with KRAS-mutant NSCLC differ among patients from various racial groups.
Cost of therapy was a major concern among a majority (69%) of patients with lung cancer who responded to the survey.
Researchers identified and validated novel risk groups models that predict OS and PFS among NSCLC patients treated with immunotherapy.
Researchers examined real-life outcomes with the PACIFIC paradigm and found that the higher incidence of pneumonitis did not affect overall survival.
Researchers also found differences in the composition of the gut microbiome between patients with lung cancer who experienced toxicity and those who did not.